300 related articles for article (PubMed ID: 21324906)
1. Late activation of stress-activated protein kinases/c-Jun N-terminal kinases triggered by cisplatin-induced DNA damage in repair-defective cells.
Helbig L; Damrot J; Hülsenbeck J; Köberle B; Brozovic A; Osmak M; Fiket Z; Kaina B; Fritz G
J Biol Chem; 2011 Apr; 286(15):12991-3001. PubMed ID: 21324906
[TBL] [Abstract][Full Text] [Related]
2. Late activation of stress kinases (SAPK/JNK) by genotoxins requires the DNA repair proteins DNA-PKcs and CSB.
Fritz G; Kaina B
Mol Biol Cell; 2006 Feb; 17(2):851-61. PubMed ID: 16319174
[TBL] [Abstract][Full Text] [Related]
3. DNA replication arrest in response to genotoxic stress provokes early activation of stress-activated protein kinases (SAPK/JNK).
Damrot J; Helbig L; Roos WP; Barrantes SQ; Kaina B; Fritz G
J Mol Biol; 2009 Feb; 385(5):1409-21. PubMed ID: 19109974
[TBL] [Abstract][Full Text] [Related]
4. Impaired synergistic activation of stress-activated protein kinase SAPK/JNK in mouse embryonic stem cells lacking SEK1/MKK4: different contribution of SEK2/MKK7 isoforms to the synergistic activation.
Wada T; Nakagawa K; Watanabe T; Nishitai G; Seo J; Kishimoto H; Kitagawa D; Sasaki T; Penninger JM; Nishina H; Katada T
J Biol Chem; 2001 Aug; 276(33):30892-7. PubMed ID: 11418587
[TBL] [Abstract][Full Text] [Related]
5. Different properties of SEK1 and MKK7 in dual phosphorylation of stress-induced activated protein kinase SAPK/JNK in embryonic stem cells.
Kishimoto H; Nakagawa K; Watanabe T; Kitagawa D; Momose H; Seo J; Nishitai G; Shimizu N; Ohata S; Tanemura S; Asaka S; Goto T; Fukushi H; Yoshida H; Suzuki A; Sasaki T; Wada T; Penninger JM; Nishina H; Katada T
J Biol Chem; 2003 May; 278(19):16595-601. PubMed ID: 12624093
[TBL] [Abstract][Full Text] [Related]
6. Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes.
Nishina H; Bachmann M; Oliveira-dos-Santos AJ; Kozieradzki I; Fischer KD; Odermatt B; Wakeham A; Shahinian A; Takimoto H; Bernstein A; Mak TW; Woodgett JR; Ohashi PS; Penninger JM
J Exp Med; 1997 Sep; 186(6):941-53. PubMed ID: 9294148
[TBL] [Abstract][Full Text] [Related]
7. The involvement of ataxia-telangiectasia mutated protein activation in nucleotide excision repair-facilitated cell survival with cisplatin treatment.
Colton SL; Xu XS; Wang YA; Wang G
J Biol Chem; 2006 Sep; 281(37):27117-25. PubMed ID: 16849332
[TBL] [Abstract][Full Text] [Related]
8. The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin.
Potapova O; Haghighi A; Bost F; Liu C; Birrer MJ; Gjerset R; Mercola D
J Biol Chem; 1997 May; 272(22):14041-4. PubMed ID: 9162025
[TBL] [Abstract][Full Text] [Related]
9. The oncogenic TEL/PDGFR beta fusion protein induces cell death through JNK/SAPK pathway.
Atfi A; Prunier C; Mazars A; Défachelles AS; Cayre Y; Gespach C; Bourgeade MF
Oncogene; 1999 Jul; 18(26):3878-85. PubMed ID: 10445851
[TBL] [Abstract][Full Text] [Related]
10. TAp73-mediated the activation of c-Jun N-terminal kinase enhances cellular chemosensitivity to cisplatin in ovarian cancer cells.
Zhang P; Liu SS; Ngan HY
PLoS One; 2012; 7(8):e42985. PubMed ID: 22900074
[TBL] [Abstract][Full Text] [Related]
11. Ku70/80 modulates ATM and ATR signaling pathways in response to DNA double strand breaks.
Tomimatsu N; Tahimic CG; Otsuki A; Burma S; Fukuhara A; Sato K; Shiota G; Oshimura M; Chen DJ; Kurimasa A
J Biol Chem; 2007 Apr; 282(14):10138-45. PubMed ID: 17272272
[TBL] [Abstract][Full Text] [Related]
12. Activation of MEK kinase 1 by the c-Abl protein tyrosine kinase in response to DNA damage.
Kharbanda S; Pandey P; Yamauchi T; Kumar S; Kaneki M; Kumar V; Bharti A; Yuan ZM; Ghanem L; Rana A; Weichselbaum R; Johnson G; Kufe D
Mol Cell Biol; 2000 Jul; 20(14):4979-89. PubMed ID: 10866655
[TBL] [Abstract][Full Text] [Related]
13. A novel SAPK/JNK kinase, MKK7, stimulated by TNFalpha and cellular stresses.
Moriguchi T; Toyoshima F; Masuyama N; Hanafusa H; Gotoh Y; Nishida E
EMBO J; 1997 Dec; 16(23):7045-53. PubMed ID: 9384583
[TBL] [Abstract][Full Text] [Related]
14. The nucleotide excision repair protein XPC is essential for bulky DNA adducts to promote interleukin-6 expression via the activation of p38-SAPK.
Schreck I; Grico N; Hansjosten I; Marquardt C; Bormann S; Seidel A; Kvietkova DL; Pieniazek D; Segerbäck D; Diabaté S; van der Horst GT; Oesch-Bartlomowicz B; Oesch F; Weiss C
Oncogene; 2016 Feb; 35(7):908-18. PubMed ID: 25982271
[TBL] [Abstract][Full Text] [Related]
15. Autophosphorylation and ATM activation: additional sites add to the complexity.
Kozlov SV; Graham ME; Jakob B; Tobias F; Kijas AW; Tanuji M; Chen P; Robinson PJ; Taucher-Scholz G; Suzuki K; So S; Chen D; Lavin MF
J Biol Chem; 2011 Mar; 286(11):9107-19. PubMed ID: 21149446
[TBL] [Abstract][Full Text] [Related]
16. Human cells deficient in transcription-coupled repair show prolonged activation of the Jun N-terminal kinase and increased sensitivity following cisplatin treatment.
Bulmer JT; Zacal NJ; Rainbow AJ
Cancer Chemother Pharmacol; 2005 Aug; 56(2):189-98. PubMed ID: 15841377
[TBL] [Abstract][Full Text] [Related]
17. Activation of ataxia telangiectasia mutated by DNA strand break-inducing agents correlates closely with the number of DNA double strand breaks.
Ismail IH; Nyström S; Nygren J; Hammarsten O
J Biol Chem; 2005 Feb; 280(6):4649-55. PubMed ID: 15546858
[TBL] [Abstract][Full Text] [Related]
18. Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin.
Folk WP; Kumari A; Iwasaki T; Pyndiah S; Johnson JC; Cassimere EK; Abdulovic-Cui AL; Sakamuro D
J Biol Chem; 2019 Apr; 294(14):5700-5719. PubMed ID: 30733337
[TBL] [Abstract][Full Text] [Related]
19. Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells.
Nehmé A; Baskaran R; Nebel S; Fink D; Howell SB; Wang JY; Christen RD
Br J Cancer; 1999 Mar; 79(7-8):1104-10. PubMed ID: 10098743
[TBL] [Abstract][Full Text] [Related]
20. Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance.
Brozovic A; Fritz G; Christmann M; Zisowsky J; Jaehde U; Osmak M; Kaina B
Int J Cancer; 2004 Dec; 112(6):974-85. PubMed ID: 15386344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
